Laboratory of Microbial Biotechnology and Bioactive Molecules, Faculty of Sciences and Technologies Faculty, Sidi Mohamed Ben Abdellah University, P.O. Box 2202, Imouzzer Road, Fez, Morocco
Auto-generated profile, based on publicly available information
Youssef Mahou
Laboratory of Microbial Biotechnology and Bioactive Molecules, Faculty of Sciences and Technologies Faculty, Sidi Mohamed Ben Abdellah University, P.O. Box 2202, Imouzzer Road, Fez, Morocco
Introduction: For thousands of years, Cannabis sativa has been used for its medical and recreational benefits. Nowadays, there is an increasing interest in the use of C. sativa and its non-psychoactive products/effects to treat certain diseases. This study was conducted to examine the gastrointestinal effects of a sequential ethanolic fraction of C. sativa threshing residues (EFCS). Methods: In vivo and in vitro approaches were used to investigate the gastrointestinal properties of EFCS. Antidiarrheal, antibacterial, spasmodic, laxative, and antiulcer effects were tested respectively against castor oil induced diarrhea, disc diffusion method, isolated tissue preparations, charcoal transit time, and ethanol induced ulcer model. Results: EFCS induced a spasmodic effect on an isolated rabbit jejunum, which was inhibited by atropine and verapamil. Moreover, under free calcium conditions, the effect of EFCS was significantly reduced. The acute toxicity assay in female and male mice showed that EFCS was a safe product. Additionally, EFCS like loperamide presented antidiarrheal effect in mice and inhibited intestinal fluid secretions. Unlike the standard drug (loperamide), EFCS increased the motility of the intestinal transit. Furthermore, EFCS showed a protective effect against gastric ulcers induced by ethanol in mice and exhibited antimicrobial properties against Bacillus cereus strains. Conclusion: The results of this study reveal that EFCS possesses anti-diarrheal, antibacterial, spasmodic, laxative, and anti-ulcer activities. EFCS has potential therapeutic use against gastrointestinal diseases. Also, our work values the non-psychoactive products of C. sativa.
25 December 2024 in Journal of Herbmed Pharmacology
Introduction: Cannabis sativa threshing residue is the plant material left after extracting resinous trichomes from the dried female plant. This study examines the phytochemical properties of C. sativa threshing residue and screens its vasorelaxant, antimicrobial, and immunomodulatory activities. Methods: The residue was extracted sequentially using hexane, dichloromethane, ethyl acetate, and ethanol. The four fractions were analyzed by gas chromatography-mass spectrometry. Phenolic and flavonoid contents were estimated using Folin-Ciocalteu reagent and aluminum chloride colorimetric methods. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay determined in vitro antioxidant activity. The vasorelaxant effect was explored using rat mesenteric arterial beds (MABs). Antimicrobial studies on Salmonella enterica, Escherichia coli, Staphylococcus aureus, and Bacillus cereus were conducted using microdilution tests. Immunomodulatory activity was determined using cell proliferation, antibody production, and complement tests. Results: Phytochemical analysis of the four fractions revealed many volatile bioactive compounds, including terpenes like phytol and squalene and cannabinoids like delta-9-tetrahydrocannabinol and cannabidiol (CBD). The fractions had significant polyphenol and flavonoid content. They dose-dependently dilated the MAB and demonstrated varying DPPH free radical scavenging activity. Immunomodulatory activity showed an immunosuppressive effect on cell proliferation and biological functions. The four bacterial strains studied were sensitive to the fractions but with different degrees. Conclusion: Cannabis sativa threshing residue demonstrated diverse pharmacological potential, suggesting its suitability for developing cannabis-based medications targeting hypertension-related damage, free radicals, and bacteria, expanding its potential applications beyond inflammation-related conditions
1 January 2023 in Evidence-Based Complementary and Alternative Medicine
Introduction. Ethanolic fraction of Moroccan Cannabis sativa threshing residues (EFCS) was evaluated for its vasorelaxant activity. The current work aims to identify the active metabolites in the ethanolic fraction of the EFCS and illustrate their mechanism of action. Methods. Free radical scavenging capacity of EFCS was assessed using DPPH method. The EFCS vasodilation activities in phenylephrine‐precontracted isolated rat mesenteric arterial beds were investigated in presence of L‐NAME (nitric oxide synthase inhibitor), indomethacin (cyclooxygenase inhibitor), potassium channel blockers (namely tetraetylamonium, barium chloride, and glibenclamide), and atropine. Nitric oxide vascular release was measured by electron paramagnetic resonance (EPR) using a spin trap in rat aortic rings. Results. EFCS induced dose‐dependent vasorelaxation on mesenteric vascular bed. Incubation of the preparations with L‐NAME, ODQ (a soluble guanylyl cyclase inhibitor), or potassium channel blockers reduced the fall of perfusion pressure caused by EFCS. Endothelial denudation or atropine abolished the EFCS’s vasorelaxant effect, suggesting involvement of muscarinic receptors and endothelium‐relaxing factors. The extract induced nitric oxide release in aortic rings in a similar manner as acetylcholine suggesting an effect of EFCS on the muscarinic receptor and the conductance arteries. Chemical investigation of EFCS identified potential active components namely apigenin and derivatives of luteolin skeleton and also additional components such as neophytadiene, squalene, and β‐sitosterol. In conclusion, the vasorelaxant effect of EFCS on rat mesenteric arterial bed, which is dependent of muscarinic receptor activation, nitric oxide, and EDHF, can account for potential therapeutic use against high blood pressure related cardiovascular diseases.